Targeting the NLRP3 inflammasome, a sensor of deleterious endogenous and exogenous stimuli, is a promising therapeutic strategy for mitigating pro-inflammatory signaling and CVD progression, particularly atherosclerosis. The gene discussed is NLRP3; the disease is atherosclerosis.